RSV Hospitalization: Persistent Symptoms & Reduced Quality of Life
Okay, here’s a breakdown of the key details from the provided text, focusing on the impact of RSV on older adults and long-term consequences:
Key Takeaways:
* RSV is a important health threat to older adults: RSV causes an estimated 100,000-150,000 hospitalizations annually in the US for those over 60, with a cost exceeding $1.5 billion.
* RSV leads to more severe outcomes than flu/COVID: RSV hospitalizations are associated with a higher likelihood of needing intensive care, mechanical ventilation, in-hospital death, and mortality within a year compared to influenza and COVID-19 hospitalizations (during the 2022-2023 seasons).
* long-term consequences are considerable: A study (SunRISE program) found that adults hospitalized with RSV experienced significant and lasting impairments in:
* Physical function
* Activities of daily living
* Shortness of breath (dyspnea)
* Self-rated health
* Quality of life
* These consequences persist irrespective of age: Even those under 60 hospitalized with RSV experienced these deficits.
* Study Details:
* 21,611 patients enrolled, 610 hospitalized with RSV.
* 146 RSV patients completed 6-12 month follow-up surveys.
* Compared RSV outcomes to a cohort of 118 COVID-19 hospitalized patients.
* The study highlights a gap in research: there was limited prior research on the long-term effects of severe RSV,especially in adults.
In essence, the text emphasizes that RSV is not just a childhood illness; it can have serious, lasting health consequences for adults, particularly older adults, and the impact is more severe than previously understood.